These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 7710378)

  • 21. A study of regional cerebral blood flow and cognitive performance in Alzheimer's disease.
    O'Brien JT; Eagger S; Syed GM; Sahakian BJ; Levy R
    J Neurol Neurosurg Psychiatry; 1992 Dec; 55(12):1182-7. PubMed ID: 1479398
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Anosognosia in Alzheimer's disease: association with patient characteristics, psychiatric symptoms and cognitive deficits.
    Kashiwa Y; Kitabayashi Y; Narumoto J; Nakamura K; Ueda H; Fukui K
    Psychiatry Clin Neurosci; 2005 Dec; 59(6):697-704. PubMed ID: 16401246
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cerebral blood flow correlates of apathy in Alzheimer disease.
    Craig AH; Cummings JL; Fairbanks L; Itti L; Miller BL; Li J; Mena I
    Arch Neurol; 1996 Nov; 53(11):1116-20. PubMed ID: 8912484
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Characteristic deterioration of ADAS-Jcog subscale scores and correlations with regional cerebral blood flow reductions in Alzheimer's disease.
    Yoshii F; Kawaguchi C; Kohara S; Shimizu M; Onaka H; Ryo M; Takahashi W
    Neurol Sci; 2018 May; 39(5):909-918. PubMed ID: 29508099
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Neuroanatomical and cognitive correlates of domain-specific anosognosia in early Alzheimer's disease.
    Valera-Bermejo JM; De Marco M; Mitolo M; McGeown WJ; Venneri A
    Cortex; 2020 Aug; 129():236-246. PubMed ID: 32534349
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A comparison of (99m)Tc-HMPAO SPET changes in dementia with Lewy bodies and Alzheimer's disease using statistical parametric mapping.
    Colloby SJ; Fenwick JD; Williams ED; Paling SM; Lobotesis K; Ballard C; McKeith I; O'Brien JT
    Eur J Nucl Med Mol Imaging; 2002 May; 29(5):615-22. PubMed ID: 11976799
    [TBL] [Abstract][Full Text] [Related]  

  • 27. 99mTc-HMPAO and 99mTc-ECD brain uptake correlates of verbal memory in Alzheimer's disease.
    Nobili F; Koulibaly PM; Rodriguez G; Benoit M; Girtler N; Robert PH; Brugnolo A; Darcourt J
    Q J Nucl Med Mol Imaging; 2007 Dec; 51(4):357-63. PubMed ID: 17220817
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Resting SPECT-neuropsychology correlation in very mild Alzheimer's disease.
    Nobili F; Brugnolo A; Calvini P; Copello F; De Leo C; Girtler N; Morbelli S; Piccardo A; Vitali P; Rodriguez G
    Clin Neurophysiol; 2005 Feb; 116(2):364-75. PubMed ID: 15661114
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Relation of anosognosia to frontal lobe dysfunction in Alzheimer's disease.
    Michon A; Deweer B; Pillon B; Agid Y; Dubois B
    J Neurol Neurosurg Psychiatry; 1994 Jul; 57(7):805-9. PubMed ID: 8021665
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Primary and secondary anosognosia for memory impairment in patients with Alzheimer's disease.
    Hannesdottir K; Morris RG
    Cortex; 2007 Oct; 43(7):1020-30. PubMed ID: 17941357
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Anosognosia in Alzheimer's disease: diagnosis, frequency, mechanism and clinical correlates.
    Starkstein SE
    Cortex; 2014 Dec; 61():64-73. PubMed ID: 25481465
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Metamemory in Alzheimer's disease.
    Souchay C
    Cortex; 2007 Oct; 43(7):987-1003. PubMed ID: 17941355
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Heterogeneity of neocortical cerebral blood flow deficits in dementia of the Alzheimer type: a [99mTc]-d,l-HMPAO SPECT study.
    Waldemar G; Bruhn P; Kristensen M; Johnsen A; Paulson OB; Lassen NA
    J Neurol Neurosurg Psychiatry; 1994 Mar; 57(3):285-95. PubMed ID: 8158175
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical associations of anosognosia in mild cognitive impairment and Alzheimer's disease.
    Mak E; Chin R; Ng LT; Yeo D; Hameed S
    Int J Geriatr Psychiatry; 2015 Dec; 30(12):1207-14. PubMed ID: 25754519
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A diagnostic formulation for anosognosia in Alzheimer's disease.
    Starkstein SE; Jorge R; Mizrahi R; Robinson RG
    J Neurol Neurosurg Psychiatry; 2006 Jun; 77(6):719-25. PubMed ID: 16549411
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Single photon emission computed tomography and apolipoprotein E in Alzheimer's disease: impact of the epsilon4 allele on regional cerebral blood flow.
    Høgh P; Knudsen GM; Kjaer KH; Jørgensen OS; Paulson OB; Waldemar G
    J Geriatr Psychiatry Neurol; 2001; 14(1):42-51. PubMed ID: 11281316
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Statistical parametric mapping of brain SPECT perfusion abnormalities in patients with Alzheimer's disease.
    Lee YC; Liu RS; Liao YC; Sun CM; Wang PS; Wang PN; Liu HC
    Eur Neurol; 2003; 49(3):142-5. PubMed ID: 12646756
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Awareness of cognitive deficits and anosognosia in probable Alzheimer's disease.
    Lopez OL; Becker JT; Somsak D; Dew MA; DeKosky ST
    Eur Neurol; 1994; 34(5):277-82. PubMed ID: 7995303
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Anosognosia in patients with Alzheimer's disease: current perspectives.
    Tagai K; Nagata T; Shinagawa S; Shigeta M
    Psychogeriatrics; 2020 May; 20(3):345-352. PubMed ID: 31930617
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Temporal lobe perfusion on single photon emission computed tomography predicts the rate of cognitive decline in Alzheimer's disease.
    Wolfe N; Reed BR; Eberling JL; Jagust WJ
    Arch Neurol; 1995 Mar; 52(3):257-62. PubMed ID: 7872878
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.